|
1
|
Ding FN, Gao BH, Wu X, Gong CW, Wang WQ
and Zhang SM: miR-122-5p modulates the radiosensitivity of cervical
cancer cells by regulating cell division cycle 25A (CDC25A). FEBS
Open Bio. 9:1869–1879. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bao HL, Liu YN, Wang LJ, Fang LW, Cong S,
Zhou MG and Wang LH: Analysis on mortality of cervical cancer and
its temporal trend in women in China, 2006–2012. Zhonghua Liu Xing
Bing Xue Za Zhi. 38:58–64. 2017.(In Chinese). PubMed/NCBI
|
|
3
|
Cohen PA, Jhingran A, Oaknin A and Denny
L: Cervical cancer. Lancet. 393:169–182. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li H, Wu X and Cheng X: Advances in
diagnosis and treatment of metastatic cervical cancer. J Gynecol
Oncol. 27:e432016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Menderes G, Black J, Schwab CL and Santin
AD: Immunotherapy and targeted therapy for cervical cancer: An
update. Expert Rev Anticancer Ther. 16:83–98. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhou Q, Dong J, Luo R, Zhou X, Wang J and
Chen F: MicroRNA-20a regulates cell proliferation, apoptosis and
autophagy by targeting thrombospondin 2 in cervical cancer. Eur J
Pharmacol. 844:102–109. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Peng RQ, Wan HY, Li HF, Liu M, Li X and
Tang H: MicroRNA-214 suppresses growth and invasiveness of cervical
cancer cells by targeting UDP-N-acetyl-α-D-galactosamine:
Polypeptide N-acetylgalactosaminyltransferase 7. J Biol Chem.
287:14301–14309. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ili CG, Brebi P, López J, García P, Leal
P, Suarez E and Roa JC: Genotyping of human papillomavirus in
cervical intraepithelial neoplasia in a high-risk population. J Med
Virol. 83:833–837. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cao XM: Role of miR-337-3p and its target
Rap1A in modulating proliferation, invasion, migration and
apoptosis of cervical cancer cells. Cancer Biomark. 24:257–267.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cooper PR, Nowak NJ, Higgins MJ, Church DM
and Shows TB: Transcript mapping of the human chromosome
11q12-q13.1 gene-rich region identifies several newly described
conserved genes. Genomics. 49:419–429. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lieber MR: The FEN-1 family of
structure-specific nucleases in eukaryotic DNA replication,
recombination and repair. Bioessays. 19:233–240. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Henneke G, Friedrich-Heineken E and
Hubscher U: Flap endonuclease 1: A novel tumour suppresser protein.
Trends Biochem Sci. 28:384–390. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kikuchi K, Taniguchi Y, Hatanaka A, Sonoda
E, Hochegger H, Adachi N, Matsuzaki Y, Koyama H, van Gent DC, Jasin
M and Takeda S: Fen-1 facilitates homologous recombination by
removing divergent sequences at DNA break ends. Mol Cell Biol.
25:6948–6955. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wu X, Wilson TE and Lieber MR: A role for
FEN-1 in nonhomologous DNA end joining: The order of strand
annealing and nucleolytic processing events. Proc Natl Acad Sci
USA. 96:1303–1308. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kucherlapati M, Yang K, Kuraguchi M, Zhao
J, Lia M, Heyer J, Kane MF, Fan K, Russell R, Brown AM, et al:
Haploinsufficiency of Flap endonuclease (Fen1) leads to rapid tumor
progression. Proc Natl Acad Sci USA. 99:9924–9929. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ayyagari R, Gomes XV, Gordenin DA and
Burgers PM: Okazaki fragment maturation in yeast. I. Distribution
of functions between FEN1 AND DNA2. J Biol Chem. 278:1618–1625.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kim IS: Down-regulation of human FEN-1
gene expression during differentiation of promyelocytic leukemia
cells. Exp Mol Med. 30:252–256. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gary R, Park MS, Nolan JP, Cornelius HL,
Kozyreva OG, Tran HT, Lobachev KS, Resnick MA and Gordenin DA: A
novel role in DNA metabolism for the binding of Fen1/Rad27 to PCNA
and implications for genetic risk. Mol Cell Biol. 19:5373–5382.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Warbrick E, Coates PJ and Hall PA: Fen1
expression: A novel marker for cell proliferation. J Pathol.
186:319–324. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nikolova T, Christmann M and Kaina B: FEN1
is overexpressed in testis, lung and brain tumors. Anticancer Res.
29:2453–2459. 2009.PubMed/NCBI
|
|
21
|
He L, Zhang Y, Sun H, Jiang F, Yang H, Wu
H, Zhou T, Hu S, Kathera CS, Wang X, et al: Targeting DNA flap
endonuclease 1 to impede breast cancer progression. EBioMedicine.
14:32–43. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang K, Xie C and Chen D: Flap
endonuclease 1 is a promising candidate biomarker in gastric cancer
and is involved in cell proliferation and apoptosis. Int J Mol Med.
33:1268–1274. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Iacobuzio-Donahue CA, Maitra A, Olsen M,
Lowe AW, van Heek NT, Rosty C, Walter K, Sato N, Parker A, Ashfaq
R, et al: Exploration of global gene expression patterns in
pancreatic adenocarcinoma using cDNA microarrays. Am J Pathol.
162:1151–1162. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lam JS, Seligson DB, Yu H, Li A, Eeva M,
Pantuck AJ, Zeng G, Horvath S and Belldegrun AS: Flap endonuclease
1 is overexpressed in prostate cancer and is associated with a high
Gleason score. BJU Int. 98:445–451. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Singh P, Yang M, Dai H, Yu D, Huang Q, Tan
W, Kernstine KH, Lin D and Shen B: Overexpression and
hypomethylation of flap endonuclease 1 gene in breast and other
cancers. Mol Cancer Res. 6:1710–1717. 2008.PubMed/NCBI
|
|
26
|
He L, Luo L, Zhu H, Yang H, Zhang Y, Wu H,
Sun H, Jiang F, Kathera CS, Liu L, et al: FEN1 promotes tumor
progression and confers cisplatin resistance in non-small-cell lung
cancer. Mol Oncol. 11:640–654. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zeng X, Che X, Liu YP, Qu XJ, Xu L, Zhao
CY, Zheng CL, Hou KZ and Teng Y: FEN1 knockdown improves
trastuzumab sensitivity in human epidermal growth factor 2-positive
breast cancer cells. Exp Ther Med. 14:3265–3272. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li JL, Wang JP, Chang H, Deng SM, Du JH,
Wang XX, Hu HJ, Li DY, Xu XB, Guo WQ, et al: FEN1 inhibitor
increases sensitivity of radiotherapy in cervical cancer cells.
Cancer Med. 8:7774–7780. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lu X, Liu R, Wang M, Kumar AK, Pan F, He
L, Hu Z and Guo Z: MicroRNA-140 impedes DNA repair by targeting
FEN1 and enhances chemotherapeutic response in breast cancer.
Oncogene. 39:234–247. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li C, Zhou D, Hong H, Yang S, Zhang L, Li
S, Hu P, Ren H, Mei Z and Tang H: TGFβ1-miR-140-5p axis mediated
up-regulation of flap endonuclease 1 promotes
epithelial-mesenchymal transition in hepatocellular carcinoma.
Aging (Albany NY). 11:5593–5612. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zeng X, Qu X, Zhao C, Xu L, Hou K, Liu Y,
Zhang N, Feng J, Shi S, Zhang L, et al: FEN1 mediates miR-200a
methylation and promotes breast cancer cell growth via MET and EGFR
signaling. FASEB J. 33:10717–10730. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hammond SM: An overview of microRNAs. Adv
Drug Deliv Rev. 87:3–14. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Di Leva G, Garofalo M and Croce CM:
MicroRNAs in cancer. Annu Rev Pathol. 9:287–314. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li L, Song Y, Shi X, Liu J, Xiong S, Chen
W, Fu Q, Huang Z, Gu N and Zhang R: The landscape of miRNA editing
in animals and its impact on miRNA biogenesis and targeting. Genome
Res. 28:132–143. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang K, Jin W, Song Y and Fei X: LncRNA
RP11-436H11.5, functioning as a competitive endogenous RNA,
upregulates BCL-W expression by sponging miR-335-5p and promotes
proliferation and invasion in renal cell carcinoma. Mol Cancer.
16:1662017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Tuddenham L, Wheeler G, Ntounia-Fousara S,
Waters J, Hajihosseini MK, Clark I and Dalmay T: The cartilage
specific microRNA-140 targets histone deacetylase 4 in mouse cells.
FEBS Lett. 580:4214–4217. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Shin VY, Ng EK, Chan VW, Kwong A and Chu
KM: A three-miRNA signature as promising non-invasive diagnostic
marker for gastric cancer. Mol Cancer. 14:2022015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zou J and Xu Y: MicroRNA-140 inhibits cell
proliferation in gastric cancer cell line HGC-27 by suppressing
SOX4. Med Sci Monit. 22:2243–2252. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yang H, Fang F, Chang R and Yang L:
MicroRNA-140-5p suppresses tumor growth and metastasis by targeting
transforming growth factor β receptor 1 and fibroblast growth
factor 9 in hepatocellular carcinoma. Hepatology. 58:205–217. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Li W, Jiang G, Zhou J, Wang H, Gong Z,
Zhang Z, Min K, Zhu H and Tan Y: Down-regulation of miR-140 induces
EMT and promotes invasion by targeting Slug in esophageal cancer.
Cell Physiol Biochem. 34:1466–1476. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Guo H, Yang S, Li S, Yan M, Li L and Zhang
H: LncRNA SNHG20 promotes cell proliferation and invasion via
miR-140-5p-ADAM10 axis in cervical cancer. Biomed Pharmacother.
102:749–757. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Chen X, Xiong D, Ye L, Wang K, Huang L,
Mei S, Wu J, Chen S, Lai X, Zheng L and Wang M: Up-regulated lncRNA
XIST contributes to progression of cervical cancer via regulating
miR-140-5p and ORC1. Cancer Cell Int. 19:452019. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Chang QQ, Chen CY, Chen Z and Chang S:
LncRNA PVT1 promotes proliferation and invasion through enhancing
Smad3 expression by sponging miR-140-5p in cervical cancer. Radiol
Oncol. 53:443–452. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Su Y, Xiong J, Hu J, Wei X, Zhang X and
Rao L: MicroRNA-140-5p targets insulin like growth factor 2 mRNA
binding protein 1 (IGF2BP1) to suppress cervical cancer growth and
metastasis. Oncotarget. 7:68397–68411. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhang K, Keymeulen S, Nelson R, et al:
Overexpression of Flap endonuclease 1 correlates with enhanced
proliferation and poor prognosis of non-small-cell lung cancer. Am
J Pathol. 188:242–251. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Pappa KI, Polyzos A, Jacob-Hirsch J,
Amariglio N, Vlachos GD, Loutradis D and Anagnou NP: Profiling of
discrete gynecological cancers reveals novel transcriptional
modules and common features shared by other cancer types and
embryonic stem cells. PLoS One. 10:e01422292015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Li JH, Liu S, Zhou H, Qu LH and Yang JH:
starBase v2.0: Decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA
interaction networks from large-scale CLIP-Seq data. Nucleic Acids
Res. 42((Database Issue)): D92–D97. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Salim H, Akbar NS, Zong D, Vaculova AH,
Lewensohn R, Moshfegh A, Viktorsson K and Zhivotovsky B: miRNA-214
modulates radiotherapy response of non-small cell lung cancer cells
through regulation of p38MAPK, apoptosis and senescence. Br J
Cancer. 107:1361–1373. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Zhang K, Keymeulen S, Nelson R, Tong TR,
Yuan YC, Yun X, Liu Z, Lopez J, Raz DJ and Kim JY: Overexpression
of flap endonuclease 1 correlates with enhanced proliferation and
poor prognosis of non-small-cell lung cancer. Am J Pathol.
188:242–251. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
He L, Luo L, Zhu H, Yang H, Zhang Y, Wu H,
Sun H, Jiang F, Kathera CS, Liu L, et al: FEN1 promotes tumor
progression and confers cisplatin resistance in non-small-cell lung
cancer. Mol Oncol. 11:1302–1303. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Zhang Y, Liu X, Liu L, Chen J, Hu Q, Shen
S, Zhou Y, Chen S, Xue C, Cui G and Yu Z: Upregulation of FEN1 is
associated with the tumor progression and prognosis of
hepatocellular carcinoma. Dis Markers. 2020:25140902020. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
He L, Yang H, Zhou S, Zhu H, Mao H, Ma Z,
Wu T, Kumar AK, Kathera C, Janardhan A, et al: Synergistic
antitumor effect of combined paclitaxel with FEN1 inhibitor in
cervical cancer cells. DNA Repair (Amst). 63:1–9. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Minna E, Romeo P, Dugo M, De Cecco L,
Todoerti K, Pilotti S, Perrone F, Seregni E, Agnelli L, Neri A, et
al: miR-451a is underexpressed and targets AKT/mTOR pathway in
papillary thyroid carcinoma. Oncotarget. 7:12731–12747. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Liu H, Ren G, Zhu L, Liu X and He X: The
upregulation of miRNA-146a inhibited biological behaviors of ESCC
through inhibition of IRS2. Tumour Biol. 37:4641–4647. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Li X, Zhang Y, Zhang H, Liu X, Gong T, Li
M, Sun L, Ji G, Shi Y, Han Z, et al: miRNA-223 promotes gastric
cancer invasion and metastasis by targeting tumor suppressor
EPB41L3. Mol Cancer Res. 9:824–833. 2011. View Article : Google Scholar : PubMed/NCBI
|
